ABBOTT INDIA
Back to Cashflow Statement
|
ABBOTT INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-745 Cr | ₹-639 Cr | ₹-637 Cr | ₹-582 Cr | ₹-217 Cr |
What is the latest Cash Flow from Financing Activities ratio of ABBOTT INDIA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-745 Cr |
Mar2023 | ₹-639 Cr |
Mar2022 | ₹-637 Cr |
Mar2021 | ₹-582 Cr |
Mar2020 | ₹-217 Cr |
How is Cash Flow from Financing Activities of ABBOTT INDIA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-745 Cr | Negative | |
Mar2023 | ₹-639 Cr | Negative | |
Mar2022 | ₹-637 Cr | Negative | |
Mar2021 | ₹-582 Cr | Negative | |
Mar2020 | ₹-217 Cr | - |
Compare Cash Flow from Financing Activities of peers of ABBOTT INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ABBOTT INDIA | ₹60,703.0 Cr | -1.4% | 3.9% | 27.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
ABBOTT INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ABBOTT INDIA | -1.4% |
3.9% |
27.2% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses